Here and Now: Inspiring Stories of Cancer Survivors --
by Elena Dorfman, Heidi Schultz Adams
Kathy's Hats: A Story of Hope Kathy's Hats: A Story of Hope
by Trudy Krisher
My Mommy's Cancer
by Cindy Klein Cohen
Beating Cancer With Nutrition
by Patrick Quillin
A Cancer Battle Plan: Six Strategies for Beating Cancer, from a Recovered "Hopeless Case"
by Anne E. Frahm, David J. Frahm
How to Fight Cancer & Win
by William L. Fischer
What to Eat if You Have Cancer
by Daniella Chace
The Cure for All Cancers: Including over 100 Case Histories of Persons Cured
by Hulda Regehr Clark
Just Get Me Through This: The Practical Guide to Breast Cancer
by Deborah A. Cohen

    Hepatocellular Cancer





    Thalidomide May Be Effective in Chronic Hepatitis C Unresponsive ... Feb 17, 2006
    Cancer Consultants (press release), Hepatitis C-associated hepatocellular cancer is increasing in incidence, while cancers related to alcohol and hepatitis B are remaining constant. ...

    New therapy points to better life Feb 10, 2006
    Arizona Daily Star, Unlike most of the 14,000 Americans who yearly develop the most common form of liver cancer, known as hepatocellular cancer, Jenkins did not have cirrhosis or ...

    Adherex Activates Phase I Trial of Eniluracil Jan 4, 2006
    Business Wire (press release), ...received orphan drug designation for the use of eniluracil in combination with fluoropyrimidines (including 5-FU) for the treatment of hepatocellular cancer. ...

    Adherex Receives FDA Orphan Drug Designation for Eniluracil in ... 21 Dec 2005
    CCNMatthews (press release), The designation was granted for the use of eniluracil in combination with fluoropyrimidines for the treatment of hepatocellular cancer. ...

    Liver Transplants from Living Donors Have Poorer Outcomes ... Nov 23, 2005
    DG News In Dr. Kulik's study of patients with cirrhosis and known hepatocellular cancer, 56 patients received a liver transplant from a living and 31 had dead donors. ...

    Interferon-Alpha Reduces Liver Cancer Risk and Mortality in ... Nov 18, 2005
    DG News Milan, Italy, and colleagues presented the largest study yet to examine whether sustained virological response reduces the risk of hepatocellular cancer (HCC). ...

    Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005
    Yahoo! News (press release) ...prostate cancer, the second-line treatment of patients with colorectal cancer, the first-line treatment of patients with hepatocellular cancer and the first ...

    Books, Journals, New Media Received -- Jun 14, 2005
    Hepatocellular Cancer: Diagnosis and Treatment edited by Brian I. Carr (Current Clinical Oncology), includes CD-ROM, 298 pp, with illus, $135, ISBN 1-58829-125 ... / Journal of American Medical Association (subscription),



    Habitual Coffee Drinking Reduces Hepatocellular Cancer in Japanese -- Feb 17, 2005
    Japanese researchers have reported that hepatocellular carcinoma (HCC) was less frequent in coffee drinkers than in abstainers. ... / Cancer Consultants (press release),


    Habitual Coffee Drinking Reduces Hepatocellular Cancer in Japanese Feb 17, 2005
    Japanese researchers have reported that hepatocellular carcinoma (HCC) was less frequent in coffee drinkers than in abstainers. ... Cancer Consultants

    Peginterferon and Ribavarin is Currently the Best Therapy for ... Aug 3, 2004
    HCV infection leads to cirrhosis and often to hepatocellular cancer. There in emerging evidence in patients who do not have HIV ... Cancer Consultants, TN -

    Vitamin K2 May Prevent Cancer of the Liver Jul 29, 2004
    Researchers from Japan have reported that women with cirrhosis due to viral infection have a lower incidence of hepatocellular cancer if they receive vitamin ... Cancer Consultants, TN -


    Lamivudine Decreases Hepatocellular Cancer in Patients with ... -- Oct 12, 2004
    Hepatocellular cancer is one of the most common cancers in the world, especially in Asia. One cause of hepatocellular cancer is ... / Cancer Consultants (press release),

    Patients with Hepatitis C with Long-Term Responses to Interferon ... -- Oct 26, 2004
    Infection with the hepatitis C virus increases a patient’s risk of developing hepatocellular cancer. Researchers continue to evaluate ... / Cancer Consultants (press release),

    Lamivudine Decreases Risk of Liver Cancer in Patients with ... -- Oct 20, 2004
    New England Journal of Medicine, treatment with the anti-viral agent lamivudine (Epir HBV®) reduces the risk of developing hepatocellular cancer in patients ... / Cancer Consultants (press release),

    Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 ß ... -- Oct 26, 2004
    Down-regulation of GADD45ß has been verified to be specific in hepatocellular cancer (HCC) and consistent with the p53 mutant, and degree of malignancy of HCC ... / Am J Pathology (subscription)

    Vitamin K2 May Prevent Cancer of the Liver -- Jul 29, 2004
    Researchers from Japan have reported that women with cirrhosis due to viral infection have a lower incidence of hepatocellular cancer if they receive vitamin ... / Cancer Consultants (press release), TN -

    Peginterferon and Ribavarin is Currently the Best Therapy for ... -- Aug 3, 2004
    HCV infection leads to cirrhosis and often to hepatocellular cancer. There in emerging evidence in patients who do not have HIV ... / Cancer Consultants (press release), TN -

    [an error occurred while processing this directive]


    Hepatocellular carcinoma (HCC, also called hepatoma or liver cancer) is a primary malignancy (cancer) of the liver. Most cases of HCC are secondary to either hepatitis infection (usually hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis). In countries where hepatitis is not endemic, most cancers in the liver are not primary HCC but metastasis (spread) of cancer from elsewhere in the body, e.g. the colon. Treatment options of HCC and prognosis are dependent on many factors but especially on tumor size and staging.

    In Sub-Saharan Africa and most other Third World countries the commonly accepted prognosis is a median survival of 3 months from diagnosis. This is partially due to late presentation with large tumours, but also the lack of medical expertise and facilities.

Home | About | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org